Medical/Pharmaceuticals
First Patient in Treatment in RhoVac's Clinical Phase IIb Study in Germany
STOCKHOLM, April 24, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, on 23rd April 2020, that the first patient in Germany is in treatment in the company's clinical phase IIb study in prostate cancer, a study entitled RhoVac-002 ("BRaVac"). The first patient in Germany is in treatment...
2020-04-24 00:37
2002
Henlius receives EU GMP Certificate for HLX02 (Trastuzumab for Injection)
SHANGHAI, April 23, 2020 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the company's drug substance (DS) line and drug product (DP) line for HLX02 trastuzumab biosimilar have successfully passed the European United (EU) Good Manufacturing Practice (GMP) on-site inspectio...
2020-04-23 22:02
3733
Lianhua Qingwen Listed in the Novel Coronavirus Pneumonia Diagnosis and Treatment Scheme for Laos
SHIJIAZHUANG, China, April 22, 2020 /PRNewswire/ -- Yiling Pharmaceutical (002603.SZ) announced that Lianhua Qingwen capsules (granules) have been added to the "Novel Coronavirus Pneumonia Diagnosis and Treatment Scheme forLaos" (Trial Version II) as the fourth traditional Chinese medicine to tre...
2020-04-23 20:00
6311
Taiwan Textile Industry Actively Helping the United States and Global Partners to Combat COVID-19 Pandemic
TAIPEI, April 23, 2020 /PRNewswire/ -- Taiwan Textile Federation (TTF), by integrating upstream, midstream, and downstream textile industries and with the help of textile manufacturers such as Formosa Plastic Group, Formosa Chemicals & Fibre Corporation, Far Eastern New Century Corporation, KNH E...
2020-04-23 19:00
2586
Signifier Medical Technologies Collaborates With Global Sleep Experts on Its Innovative Snoozeal(R) Device Clinical Trials
LONDON, April 23, 2020 /PRNewswire/ -- Signifier Medical Technologies, an innovator in the sleep disordered breathing market, today announced that it is partnering with twenty-seven Key Opinion Leaders in Sleep to test and build awareness around its Snoozeal® product in the lead up to its commerc...
2020-04-23 19:00
1882
MiRXES to mass produce and distribute A*STAR Singapore's tested and proven SARS-CoV-2 RT-PCR test
SINGAPORE, April 23, 2020 /PRNewswire/ -- MiRXES, a homegrown Singapore-based biotech, has received Provisional Authorisation from the Health Sciences Authority (HSA)Singapore, to supply the Fortitude Kit SARS-CoV-2 real-time RT-PCR[1] test. With technology licensed from Singapore's Agency for Sc...
2020-04-23 18:04
3244
Luye Pharma Group Selects LifeSphere® Signal and Risk Management to Automate Drug Safety Signal Detection
MIAMI, April 23, 2020 /PRNewswire/ -- ArisGlobal, the leading provider of life sciences software that automates core drug development functions for over 250 life sciences companies, today announced Luye Pharma Group, an international pharmaceutical company dedicated to the R&D, manufacturing, and...
2020-04-23 13:00
2576
New Early Breast Cancer Drug Available Now In Singapore
* NERLYNX® (neratinib) now commercially available in Singapore for HER2+ breast cancer patients following adjuvant trastuzumab-based therapy * Five-year follow up data show NERLYNX reduces risk of invasive disease recurrence by 42% in women with early-stage, HER2+/HR+ breast cancer and who co...
2020-04-23 12:33
2209
Bugworks Raises US$7.5M From a Global Investment Syndicate to Combat the Global Challenge Posed by Deadly Bacterial Superbugs
BANGALORE, India; WILMINGTON, Delaware and ADELAIDE, Australia, April 23, 2020
/PRNewswire/ -- Bugworks Research Inc
2020-04-23 11:30
3328
Samsung Biologics and ImmuneOncia Therapeutics Inc. Development and Manufacturing Agreement Accomplishes IND Clearance of IMC-002 (anti-CD47 antibody)
SONGDO, South Korea, April 22, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and ImmuneOncia Therapeutics Inc. announced the successful FDA IND approval of IMC-002 under a development and manufacturing agreement with Samsung Biologics since 2018. As a result, ImmuneOncia will begin Phase 1 ...
2020-04-23 08:00
1507
OncoQuest Announces Signing of a Definitive Agreement to Sell Drug Portfolio to Dual Industrial for U.S. $300 Million and Commitment to Fund the Oregovomab Phase 3 Clinical Trial in Frontline Ovarian Cancer
EDMONTON, Alberta, April 23, 2020 /PRNewswire/ -- OncoQuest Inc., ("OncoQuest" or the "Company") a privately held, cancer immunotherapy company today announced that it has entered into a definitive agreement to sell its clinical and preclinical immunotherapy development assets to Dual Industrial ...
2020-04-23 01:38
8289
Icelandic Genomes Elucidate Neanderthal Heritage of Europeans
Archaic genetic fragments comprising nearly half the Neanderthal genome are circulating in the European gene pool today The average European carries more than 500 such archaic fragments, including SNPs linked to prostate cancer risk, iron retention, blood clotting speed, and height REYKJAVIK, I...
2020-04-23 01:33
3326
Xi'an Launches Anti-pandemic Cooperation with Her International Sister Cities
XI'AN, China, April 22, 2020 /PRNewswire/ -- On April 10, a special video conference took place in the ancient city ofXi'an in northwest China, according to Xi'an Municipal Government. An expert team comprised of professors from the First Affiliated Hospital of Xi'an Jiaotong University shared ex...
2020-04-22 21:30
1212
British Vlogger Stuart Releases Viral Video of Sinopec Yanshan Factory that Draws Million Views in Hours
BEIJING, April 22, 2020 /PRNewswire/ -- A close-up video of production lines in Sinopec ("Sinopec", HKG: 0386) Yanshan Factory was recorded and released on the social account of Stuart, a British vlogger who lived inChina, to showcase how disposable facial masks and KN95 masks are made from polyp...
2020-04-22 18:10
6651
Searefico Group: Donating 'Unique' Isolated Negative Pressure Rooms to fight against COVID-19
HO CHI MINH CITY, Vietnam, April 22, 2020 /PRNewswire/ -- On April 18, 2020, Searefico Group has donated the first Isolated Negative Pressure Room (INPR) to HCMC Department of Health. This donation is in line with the company's3 billion VND package funding for the COVID-19 prevention and control ...
2020-04-22 16:34
2901
Getinge Interim Report for January-March 2020: Intense Efforts to Help Hospitals in the COVID-19 Pandemic
GOTHENBURG, Sweden, April 22, 2020 /PRNewswire/ -- "The quarter was dominated by the COVID-19 pandemic and the huge need for advanced ventilators and ECMO therapy at intensive care units around the world. Our leading global positions in these fields contributed to a 47% organic order growth, says...
2020-04-22 14:37
5912
Icon Group Committed to Uninterrupted Cancer Care in ASEAN
SINGAPORE, April 22, 2020 /PRNewswire/ -- Patients in Singapore and the ASEAN region can now receive care as close to home as possible through Icon Cancer Centres' remote support services which include telemedicine and home delivery for medication. This service ensures minimal disruption to the c...
2020-04-22 11:00
2292
WuXi Biologics Completed Acquisition of a Drug Product Manufacturing Facility in Germany
SHANGHAI and LEVERKUSEN, Germany, April 22, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed the acquisition deal with Bayer for a drug product manufacturing plant in Leverkusen,Ge...
2020-04-22 08:00
2323
Standigm selects CDD Vault to augment its Drug Discovery AI technology
The hosted informatics platform will facilitate the advancement of Standigm's collaborative drug discovery projects SEOUL, South Korea and SAN FRANCISCO, April 22, 2020 /PRNewswire/ -- Originally published here: https://www.collaborativedrug.com/standigm-selects-cdd-vault-augment-drug-discovery-a...
2020-04-22 08:00
1967
Seegene's Allplex™ 2019-nCoV Assay receives FDA Emergency Use Authorization
SEOUL, South Korea, April 22, 2020 /PRNewswire/ -- Seegene, Inc. announced that U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for its Allplex™ 2019-nCoV Assay, a Real-time RT-PCR test for SARS-CoV-2, the novel coronavirus responsible for the COVID-19 disease. ...
2020-04-22 07:40
2554
Week's Top Stories
Most Reposted
Cornerstone Robotics Raises over US$70 million Funding to Forge Accessibility in Robotic Surgery
[Picked up by 323 media titles]
2025-01-13 09:05
URBAN REVIVO Celebrates Lunar New Year with Unique Collaboration with Artist Mercedes Bellido
[Picked up by 293 media titles]
2025-01-13 10:44
RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility
[Picked up by 286 media titles]
2025-01-14 21:00
Gen Z Travelers Drive Buy Now, Plan Later Travel Bookings by Over 20%: Fliggy's 2024 Buy Now Plan Later Travel Insight
[Picked up by 286 media titles]
2025-01-10 16:04VANTAGE FOUNDATION SUPPORTS GRAB INDONESIA IN EMPOWERING WOMEN DRIVER-PARTNER
[Picked up by 280 media titles]
2025-01-09 18:26
Most Read
Hyundai Motor Group Partners with NVIDIA to Accelerate Development of AI Solutions for Future Mobility
2025-01-10 01:00
20322
AIMA Unveils Game-Changing 2025 eBike Lineup at CES: Better Performance, More Freedom
2025-01-09 02:34
6480
RingConn Takes Center Stage at CES 2025 with Innovative Wearables: Gen 2 and Gen 2 Air
2025-01-11 01:00
5610
Boqii Announces ADS Ratio Change
2025-01-11 05:30
4945
Sino Land Included in Dow Jones Sustainability World Index
2025-01-10 22:01
4926
